NDAINTRATHECALINJECTABLE
Approved
Oct 1979
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
GARAMYCIN (gentamicin sulfate) by Merck & Co. is clinical pharmacology gentamicin sulfate is a wide spectrum antibiotic that provides highly effective topical treatment in primary and secondary bacterial infections of the skin. First approved in 1979.
Drug data last refreshed 8h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
GARAMYCIN (gentamicin sulfate) is a wide-spectrum aminoglycoside antibiotic available as an injectable formulation for intrathecal administration, primarily indicated for pneumonia. It provides bactericidal activity against susceptible gram-positive and gram-negative organisms including Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli by inhibiting bacterial protein synthesis.
LOE Approaching
With LOE approaching and no current Part D spending data reported, GARAMYCIN is in portfolio maintenance mode with reduced team investment and limited growth opportunities.
Mechanism of Action
CLINICAL PHARMACOLOGY Gentamicin sulfate is a wide spectrum antibiotic that provides highly effective topical treatment in primary and secondary bacterial infections of the skin. Gentamicin Sulfate Cream may clear infections that have not responded to treatment with other topical antibiotic agents.…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
GARAMYCIN offers minimal career growth due to its mature, genericized status and approaching/current LOE landscape. Roles available are primarily in operations, manufacturing, and post-market compliance rather than commercial brand-building or innovative development.
Worked on GARAMYCIN at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.